fbpx mmnews


Gilead sets price tag for COVID-19 drug remdesivir

LOS ANGELES: Gilead Sciences priced its COVID-19 antiviral remdesivir at $2,340 per patient in developed countries and agreed to send nearly all of its supply of the drug to the United States over the next three months. The price tag

Gilead targets remdesivir for two million COVID-19 patients

WASHINGTON: Gilead Sciences has doubled its target and is now expecting to supply enough of its antiviral drug remdesivir by year-end to treat more than two million COVID-19 patients. The company also hopes to start trials in August of an

Pakistan to produce anti-viral drug Remdesivir within two months

ISLAMABAD: A Pakistani pharmaceutical company will manufacture the anti-viral drug Remdesivir which had been approved to treat coronavirus patients. Special Assistant on National Health Services Dr Zafar Mirza said the drug will be manufactured within two months and will also